Evaluation of Intra-articular Injuries as Predictors of Function and Arthritis

March 06, 2007

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Robert G. Marx, MD

Co-Investigators

Sean Wilson

Summary

We will enroll patients of Dr. Robert Marx who undergo ACL reconstruction surgery.  Approximately 150 patients will be enrolled.  Patients receive follow up questionnaires at two, six and ten years after their surgery.

Inclusion/Exclusion Criteria

Inclusion criteria:

• Patients undergoing unilateral ACL reconstruction
• Age range: 10-85 years

Exclusion criteria:

• Patients having had simultaneous bilateral ACL reconstruction
• Age: <10 years, >85 years
   

Contact Information

Robert Marx MD
212.606.1645

Research Coordinator:
Sean Wilson
646. 797.8411
wilsonse@hss.edu